BIODEFENSE SPECIALISTS
Experts in Contamination Control
Our mission is to protect spaces against invisible threats, whether particulate, biological, chemical, or radioactive.
At Ventum, we are a dedicated team of scientists and engineers at the forefront of hygiene innovation. Our mission centers on developing sustainable technologies for air and surface treatment, addressing today's pressing environmental and spatial challenges.
Through the collaborative efforts of our Scientific Board and strategic partners, Ventum harnesses a diverse array of technical knowledge. This multidisciplinary approach enables us to create ingenious solutions, tailored to meet a broad spectrum of needs in the quest for a cleaner, healthier world.
With a rich heritage spanning over three decades, Ventum stands as a beacon of innovation in contamination control. Our foundation is built on profound expertise in microbiology and biochemistry, tailored specifically to advance the sectors of Health, Life Sciences, and Pharma.
At the heart of our operations is a steadfast commitment to the creation and delivery of state-of-the-art decontamination solutions. Ventum is dedicated to elevating standards and exceeding expectations, ensuring that our partners and clients are equipped with the most effective tools to meet their critical hygiene and safety requirements.
Discover the Ventum difference, where experience and innovation converge to redefine decontamination.
Ventum Divisons | Engineering • Manufacturing • CQV Services
Meet the Team
-
Gina Bandar
Chief Executive Officer
-
John Murphy
Chief Financial Officer
-
Alex Kachou
Chief Technology Officer
-
Loutfi Kachou
Chief Scientific Officer
-
Alex Goins
Chief Operating Officer
-
John O'Brien
Chief Legal Officer
Ventum Scientific Board
Loutfi Kachou, PhD
Chief Scientific Officer
Dr. Kachou, creator of Ventum One-Touch™, is a leading expert in microbiological decontamination with 35 years of experience. He notably established France's solely active BSC Type 4 for Ebola cases at CHU Bordeaux, under national decree, and has been significantly involved with RNSA, l'ASPEC, and the CNRS.
Hervé Fleury, MD-PhD
Scientific Officer, Virology
Dr. Fleury, an eminent virology professor at the University of Bordeaux, co-founded an HIV unit with WHO in 2009 and specializes in tracking viruses globally. He collaborated with Dr. Kachou to establish the esteemed BSC Type 4 for Ebola manipulation.
Laurent Mairot, MD–PharmD
Scientific Officer, Pharma
Dr. Mairot, Head Pharmacist at Aesio’s Beau-Soleil Clinic and a hygienist pharmacist, uniquely combines expertise in hospital hygiene and pharmacology, driving innovation and evidence-based practices in medical and pharmaceutical care.
Jean-Claude Teulade, PharmD-PhD
Scientific Officer, Biochemistry
Dr. Teulade, a biochemistry professor emeritus at Clermont Ferrand, collaborates on Ventum One-Touch™ research with Dr. Kachou, focusing on enzyme-related industry challenges. He also evaluates theses on antioxidants, anti-parasites, and antivirals.